Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia

The intrinsic humoral immunodeficiency of chronic lymphocytic leukemia (CLL) is often managed with immunoglobulin replacement therapy (IgRT) to maintain IgG levels in the low-normal range (6–8 g/L) but optimal targets for IgG and timing to commence IgRT are unclear. IgG levels fell near 6 g/L at rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaner, David E., Venema, Robertson, Huang, Justin, Norris, Peter, Lazarus, Alan, Wang, Guizhi, Shi, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156707/
https://www.ncbi.nlm.nih.gov/pubmed/30174282
http://dx.doi.org/10.1016/j.ebiom.2018.08.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156707/
https://www.ncbi.nlm.nih.gov/pubmed/30174282
http://dx.doi.org/10.1016/j.ebiom.2018.08.045

Ejemplares similares